Honz Pharmaceutical Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 451.72 million compared to CNY 349.17 million a year ago. Revenue was CNY 451.72 million compared to CNY 349.17 million a year ago.

Net loss was CNY 20.45 million compared to CNY 109.61 million a year ago. Basic loss per share from continuing operations was CNY 0.0454 compared to CNY 0.2436 a year ago. Diluted loss per share from continuing operations was CNY 0.0454 compared to CNY 0.2436 a year ago.